Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: LncRNA FOXD3-AS1 promoted chemo-resistance of NSCLC cells via directly acting on miR-127-3p/MDM2 axis

Fig. 5

FOXD3-AS1 knockdown enhanced cisplatin sensitivity of A549/DDP cells in vivo. a Growth curve of xenograft tumors after different treatments. b Weights of dissected tumors in different groups. c qRT-PCR determination of FOXD3-AS1 expression in dissected tumor tissues in different groups. N = 6 biological samples, and each sample for FOXD3-AS1 expression was assayed in triplicates. Significant differences between groups were shown as *P < 0.05

Back to article page